Navigation Links
Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results
Date:8/22/2007

SEATTLE, Aug. 22 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) announced today that results from a series of HIV vaccine Phase 2a clinical trials, using a plasmid DNA (pDNA) vaccine developed by the NIH Vaccine Research Center and manufactured by Vical, reinforced previously reported Phase 1 conclusions that a "DNA prime-adenoviral vector boost" vaccine regimen was safe and well-tolerated, and was effective in inducing T-cell immune responses in up to 70% of the vaccine recipients.

"These recent vaccine trials contribute to the growing body of knowledge demonstrating plasmid DNA priming as a key factor in achieving significant immune responses against HIV, a particularly difficult target pathogen, bringing us one step closer to evaluating the effectiveness of a prime-boost HIV vaccine regimen in a prophylactic setting," said Vijay B. Samant, Vical's President and Chief Executive Officer. "The latest International AIDS Vaccine Initiative (IAVI) listing of ongoing preventive HIV vaccine clinical trials shows that more than half use pDNA either alone or in combination with other vaccine modalities. We are very pleased that DNA technology is an integral part of the effort to address this high priority global health problem."

The trials involved priming an immune response with three doses of a pDNA vaccine over a two month period, based on Vical's proprietary DNA technology, and boosting the response with a single dose of adenoviral vector vaccine at six months. The three trials, collectively known as TRIAD, were conducted by the National Institute of Allergy and Infectious Diseases (NIAID) HIV Trials Vaccine Network (HVTN), the IAVI, and the U.S. Military HIV Research Program (USMHRP). Richard Koup, M.D., Chief of Immunology at the Dale and Betty Bumpers Vaccine Research Center (VRC), NIAID, National Institutes of Health (NIH), highlighted TRIAD summary results and conclusions in an oral presentation, "Update on safety and immunogenicity
'/>"/>

SOURCE Vical Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "China Orthopedic Instrument Industry Report, 2014-2017" report ... aging population and rising proportion of reimbursement for medical ... effectively released, with its scale presenting a CAGR of ... products are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... According to a new ... type (SFE, Cold Pressed, Organic Solvent, & Others), and ... Fragrance, & Others) - Global Trends & Forecast ... the Amaranth Seed Oil Market with an analysis ... of value. The Amaranth Seed Oil Market size ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... Second Generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, ... of Treatment , , SAN DIEGO, June ... its Phase 2 clinical trial evaluating the safety and ... the treatment of severe complicated skin and skin structure ...
... sets to be released-- , , PARIS, ... in patients with blepharospasm and cervical dystonia -- one placebo-controlled ... presented at the Movement Disorder Society (MDS) 13th annual International ... Pharmaceuticals, which plans to file a Biologic License Application (BLA) ...
Cached Medicine Technology:Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 2Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 3Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections 4Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting 2Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting 3Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting 4
(Date:8/29/2014)... San Francisco, CA (PRWEB) August 30, 2014 ... the 10 best web conference providers in the online ... Amongst the list were global leaders Webex, GotoMeeting and ... in the industry users have to determine which provider ... Essentially, web conference businesses search for compelling consumer ...
(Date:8/29/2014)... 2014 Honey Gifts, premium Vancouver adult ... now be selling purse-sized adult toys and erotic products. ... they can be carried in a woman’s purse with ... range at Honey Gifts is also leak-free and will ... rechargeable batteries are common characteristics of Honey Gifts’ portable ...
(Date:8/29/2014)... 29, 2014 Sansego is ... an interactive online community, and a range of personalized ... all the way to professional athletes. Crowie has brought ... been with him throughout the majority of his triathlon ... in the triathlon public. , Sansego provides the following:, ...
(Date:8/29/2014)... Work is the recipient of a ... Drug Abuse (NIDA) at the National Institutes of Health (NIH) ... use. Additionally, the grant provides resources to create the infrastructure ... use has increased steadily since 2007 according to NIDA, as ... and more available opioid. , A primary project at ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Ethane Web ... recently launched a new service named HTML web design. ... based service. Before tailoring the service, Ethane Web Technologies ... other companies. The company has done its best efforts ... and able to deliver outstanding results to clients. ...
Breaking Medicine News(10 mins):Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3Health News:$1.25 million NIH grant to aid research on impact of heroin use 2Health News:Ethane Web Technologies Launches a New Web Design Service 2
... , NEW YORK, Sept. 22 Reportlinker.com ... in its catalogue. , , ... and Healthcare Transaction Processing, 3rd Edition , The ... , , The North American market ...
... News media and scientists interested in finance, entrepreneurships and ... Chemical Society (ACS) Small & Medium Business Webinar on ... ) Small Business Innovation Research (SBIR) priority funding ... 24, 2 3 p.m. Eastern Time, the webinar ...
... think the air outside is polluted, a new research report ... ( http://www.genetics.org ) might make you to think twice ... show how about 3 percent of the air we breathe ... Specifically, these superoxides lead to the creation of a toxic ...
... BRYAN, Ohio, Sept. 22 For most ... more and more children are diagnosed with allergies and intolerances to ... leave many kids feeling left out. Spangler Candy Company ... inviting kids back in on all the fun. , , ...
... , MERRIAM, Kan., Sept. 22 ... . ." t-shirts to be auctioned off to benefit Christina ... National Denim Day on October 2, one of the largest single ... To view the Multimedia News Release, go to: ...
... CEDAR KNOLLS, N.J., Sept. 22 ScienceFirst is ... as a result of ScienceFirst,s sustained annual growth. , ... senior account director at ScienceFirst, where he will be ... delivery. Before joining ScienceFirst, Steen held the position of ...
Cached Medicine News:Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 2Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 3Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 4Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 5Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 6Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 7Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 8Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 9Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 10Health News:Reportlinker Adds North American Market for Third Party Payroll, Payment and Healthcare Transaction Processing, 3rd Edition , The Report 11Health News:New research provides new insight into age-related muscle decline 2Health News:Spangler Helps Children with Food Allergies and Intolerances Enjoy a Worry-Free Halloween 2Health News:Video: Celebrities Join Christina Applegate to Share Their Heart for Breast Cancer Awareness 2Health News:Video: Celebrities Join Christina Applegate to Share Their Heart for Breast Cancer Awareness 3Health News:Video: Celebrities Join Christina Applegate to Share Their Heart for Breast Cancer Awareness 4
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Medicine Products: